Mylan (NASDAQ:MYL) will be announcing its earnings results before the market opens on Wednesday, February 28th. Analysts expect the company to announce earnings of $1.42 per share for the quarter.
Shares of Mylan (NASDAQ:MYL) opened at $41.45 on Monday. Mylan has a twelve month low of $29.39 and a twelve month high of $47.82. The company has a current ratio of 1.46, a quick ratio of 0.95 and a debt-to-equity ratio of 1.05. The company has a market cap of $22,240.00, a price-to-earnings ratio of 24.97, a P/E/G ratio of 1.12 and a beta of 1.35.
In other Mylan news, CEO Heather M. Bresch sold 75,000 shares of Mylan stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $45.00, for a total value of $3,375,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.69% of the stock is currently owned by insiders.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.